Key information

Qualification type


Subject areas

Medicine (General) Mental Health Nursing (General)

Course type


Course summary

The clinical interests of the Division are in the treatment of acute stroke, enhancing recovery and preventing recurrence; the following multicentre trials are coordinated by the Stroke Trials Unit: ultra-acute lowering of blood pressure before hospitalisation (RIGHT trial); hyperacute cooling/hypothermia (EU FP-7 trial); hyperacute tranexamic acid for primary intracerebral haemorrhage (HTA TICH-2 trial); acute lowering of BP in hospital (MRC ENOS trial of glyceryl trinitrate); acute intensive antiplatelets for preventing early recurrence (BHF-HTA TARDIS trial); prevention of post stroke cognitive impairment (TSA-AS PODCAST trial); chronic mobilisation of endogenous stem cells (RfPB STEMS-3 trial of granulocyte colony stimulating factor); the translational studies aim to identify a series of novel therapeutic targets that can subsequently be employed in clinical settings to prevent and/or reverse ischaemic injury-mediated breakdown of the blood-brain barrier and the ensuing formation of brain oedema which accounts for the majority of deaths within the first week after an ischaemic stroke; in this regard, the currently ongoing projects focus on pro-inflammatory cytokines, notably TNF-alpha and Interleukin-1beta; NADPH oxidase enzyme system and oxidative stress; matrix metalloproteinases, Plasminogen-plasmin system components; hypothermia.

Different course options

Full time | Queen's Medical Centre | 2 - 3 years | Contact University

Study mode

Full time


2 - 3 years

Start date

Contact University

Tuition fees

UK fees

For this course (per year)


Average for all Postgrad courses (per year)


International fees

For this course


Average for all Postgrad courses (per year)


Entry requirements

2.1 degree in relevant subject; appropriate English language qualifications where necessary.


Queen's Medical Centre



Nearest train station:

Nottingham 1.0 Miles away